New drug cocktail shows promise in slowing tough kidney cancers
Disease control
Ongoing
This study tests whether a combination of three drugs (cabozantinib, nivolumab, and ipilimumab) can safely slow the growth of advanced kidney cancer that has spread. About 60 adults with certain types of kidney cancer that cannot be removed by surgery will receive the treatment. …
Phase: PHASE2 • Sponsor: Bradley A. McGregor, MD • Aim: Disease control
Last updated May 22, 2026 14:05 UTC